Leidos, a leading provider of industry and technology solutions, has committed $10 million to accelerate the use of artificial intelligence (AI) for detecting and managing diseases. This five-year collaboration with the University of Pittsburgh’s Computational Pathology and AI Center of Excellence (CPACE) aims to develop AI-powered tools for quicker detection of diseases, such as heart disease and cancer, and enable earlier, more effective care management.
Expanding Access to Healthcare
The partnership’s initial focus is on developing AI-powered tools that will reduce diagnostic turnaround times and improve the accuracy of disease diagnosis. According to Leidos CEO Tom Bell, “Our investment is aimed at using the transformative power of artificial intelligence to speed detection, diagnosis and treatment of diseases that affect millions of people annually.” The collaboration will also focus on developing future health care specialists and expanding care to underserved communities, including veterans.
Key Objectives of the Leidos-University of Pittsburgh Collaboration
The collaboration has several key objectives, including:
- Establishing a World-Class Research Hub: The University of Pittsburgh will enhance CPACE by continuing development of its state-of-the-art Digital Pathology Research Center.
- Developing Digital Health Care Solutions: Advancing AI-powered technologies will enable Leidos to develop innovative solutions designed to support digital health and diagnostics.
- Accelerating Global Impact: Leidos plans to leverage the collaboration to deploy AI-powered digital pathology solutions across public and private health care sectors.
Benefits of the Partnership
The partnership will drive advances in several critical areas, including:
- Research & Technology Development: Joint research projects will explore new imaging methods, advanced scanning technologies to analyze tissue samples, and improved techniques for analyzing medical images with precision.
- Workforce Development & Education: The initiative will cultivate the next generation of health care and AI innovators through comprehensive educational programs.
Real-World Applications
The collaboration has real-world applications, including:
“The University of Pittsburgh’s leadership in research and innovation, coupled with the expertise in technology solutions offered by Leidos, establishes a path forward to delivering advancements in diagnosis, disease management and health care delivery,” said Anantha Shekhar, senior vice chancellor for the health sciences and John and Gertrude Petersen Dean, University of Pittsburgh School of Medicine.
About Leidos and University of Pittsburgh School of Medicine
Leidos is an industry and technology leader serving government and commercial customers with smarter, more efficient digital and mission innovations. The University of Pittsburgh School of Medicine is one of the nation’s leading academic centers for biomedical research.
| Company | Headquarters | Employees | Annual Revenues |
|---|---|---|---|
| Leidos | Reston, Virginia | 48,000 | $16.7 billion |
| University of Pittsburgh School of Medicine | Pittsburgh, Pennsylvania | N/A | N/A |
Conclusion
The Leidos-University of Pittsburgh partnership is poised to redefine the future of healthcare delivery and disease management. By merging academic excellence with technological innovation, the collaboration will drive advances in several critical areas and have a significant impact on the global healthcare landscape.
news is a contributor at Soozo. We are committed to providing well-researched, accurate, and valuable content to our readers.
